abstract |
Human Papilloma Virus (HPV) fusion proteins, linked to an immunological fusion partner that provides T helper epitopes to the HPV antigen, are disclosed. Vaccine formulations are provided that are useful in the treatment or Prophylaxis of HPV induced lesions. |